Market Cap 12.54B
Revenue (ttm) 4.72B
Net Income (ttm) -232.00M
EPS (ttm) N/A
PE Ratio 23.04
Forward PE 21.75
Profit Margin -4.92%
Debt to Equity Ratio 0.59
Volume 4,153,300
Avg Vol 6,226,502
Day's Range N/A - N/A
Shares Out 499.62M
Stochastic %K 88%
Beta 1.67
Analysts Strong Sell
Price Target $31.54

Company Profile

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 877 352 6261
Address:
450 Elanco Circle, Indianapolis, United States
prismmarketview
prismmarketview Aug. 26 at 5:34 PM
Happy National Dog Day from PRISM MarketView! Somewhere along the way, dogs went from pets to family, and we spend on them like it. That devotion is one of the market's most durable themes, and you can trace it right across PRISM's Pet Care index: At the vet: Elanco's $ELAN once-daily itch pill for dogs, Zenrelia, just crossed blockbuster status and now reaches ~18,000 U.S. clinics, going head-to-head with Zoetis's Apoquel in a ~$1.7B canine dermatology market. It helped lift Elanco's full-year outlook this month. At the bowl: fresh and premium food ( $FRPT ) keeps turning "dog food" into a category we obsess over. At the checkout: $CHWY and $WOOF (Petco) handle the food, toys, and grooming runs; Petco reports earnings this Thursday. At the safety net: pet insurance ( $TRUP ) is now a real household line item, because we cover them like our own. From the exam room to the food bowl, caring for our dogs is a resilient (and growing) market.
0 · Reply
Jblack500
Jblack500 Aug. 25 at 7:20 PM
$VRTX $MRK $ELAN $HALO forgot to mention HALO new ath as well. Phenomenal earnings recently
0 · Reply
Jblack500
Jblack500 Aug. 25 at 7:19 PM
$VRTX $MRK $ELAN a few new ath's in some of my bios in vrtx mrk...elan reclaimed 50 day ma today. Quite a bit of insider buying in ELAN after earnings
0 · Reply
TaoistTrader
TaoistTrader Aug. 25 at 10:29 AM
0 · Reply
Form4Alerts
Form4Alerts Aug. 21 at 9:08 PM
$ELAN — Director Lawrence Erik Kurzius bought $936K · This increased their stake by 27%. · Largest purchase they've ever made in it. Not investment advice.
0 · Reply
Jblack500
Jblack500 Aug. 20 at 12:05 AM
$MRK $VRTX $GILD $HALO $ELAN ARWR BMY ANIP (May be looking at adding REGN with this breakout) https://www.fool.com/coverage/filings/2026/08/19/director-s-confidence-visible-as-elanco-leader-buys-10-000-shares/
0 · Reply
Jblack500
Jblack500 Aug. 18 at 5:15 PM
$VRTX $ELAN $MRK $GILD $HALO ARWR BMY current basket...vrtx recent new position...added to ELAN today. Sell-off after er created opportunity. Multiple insiders made open market buys on 8/7 near this level.
0 · Reply
STACKD0E
STACKD0E Aug. 17 at 5:57 PM
0 · Reply
MisterBizness
MisterBizness Aug. 13 at 10:38 PM
$ELAN nice s
0 · Reply
topstockalerts
topstockalerts Aug. 13 at 8:09 PM
Fitch Ratings upgraded Elanco Animal Health’s Long-Term Issuer Default Rating to ‘BB+’ from ‘BB’, while raising its senior secured debt rating to ‘BBB-’ from ‘BB+’ and senior unsecured debt to ‘BB+’ from ‘BB’. The outlook remains stable. The upgrade reflects Elanco’s improved competitive position, market-share gains in pet health, broad product portfolio, consistent cash generation and conservative financial policy. Since 2024, the company has reduced debt by approximately $650M through June 30, 2026, while EBITDA has increased more than 10%. Fitch expects leverage to remain below 3.5x and decline toward 3.0x by the end of 2027. Fitch forecasts free cash flow to improve from $345M in 2026 to about $575M in 2028, driven by innovation-led margin expansion, cost savings, productivity gains and working-capital management. EBITDA margins are expected to reach 21% in 2026 and remain around 21%-22% thereafter. $ELAN
0 · Reply
Latest News on ELAN
Elanco CLiK Extra receives FDA Emergency Use Authorization

2026-08-07T18:40:32.000Z - 19 days ago

Elanco CLiK Extra receives FDA Emergency Use Authorization


Elanco CEO on Boosted Forecast, Surge in Tick Bites

Aug 6, 2026, 5:31 PM EDT - 20 days ago

Elanco CEO on Boosted Forecast, Surge in Tick Bites


Elanco price target raised to $33 from $31 at UBS

2026-08-06T12:45:40.000Z - 20 days ago

Elanco price target raised to $33 from $31 at UBS


Elanco price target raised to $34 from $31 at Citi

2026-08-06T10:54:47.000Z - 20 days ago

Elanco price target raised to $34 from $31 at Citi


Elanco price target raised to $30 from $29 at KeyBanc

2026-08-06T10:54:18.000Z - 20 days ago

Elanco price target raised to $30 from $29 at KeyBanc


Elanco Animal Health Earnings Call Transcript: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 21 days ago

Elanco Animal Health Earnings Call Transcript: Q2 2026


Elanco Animal Health Earnings release: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 21 days ago

Elanco Animal Health Earnings release: Q2 2026


Elanco Animal Health Slides: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 21 days ago

Elanco Animal Health Slides: Q2 2026


Elanco Animal Health Quarterly report: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 21 days ago

Elanco Animal Health Quarterly report: Q2 2026


Elanco reports Q2 adjusted EPS 34c, consensus 27c

2026-08-05T10:41:21.000Z - 21 days ago

Elanco reports Q2 adjusted EPS 34c, consensus 27c


Elanco Animal Health Reports Second Quarter 2026 Results

Aug 5, 2026, 6:27 AM EDT - 21 days ago

Elanco Animal Health Reports Second Quarter 2026 Results


Elanco price target raised to $26 from $23 at Morgan Stanley

2026-07-22T12:27:03.000Z - 5 weeks ago

Elanco price target raised to $26 from $23 at Morgan Stanley


Elanco price target raised to $32 from $31 at TD Cowen

2026-06-18T12:03:29.000Z - 2 months ago

Elanco price target raised to $32 from $31 at TD Cowen


Elanco to launch Elanco Ventures for animal health innovation

2026-06-18T11:30:13.000Z - 2 months ago

Elanco to launch Elanco Ventures for animal health innovation


Elanco announces USDA approval of TruCan Ultra Lyme-L4

2026-06-15T12:50:23.000Z - 2 months ago

Elanco announces USDA approval of TruCan Ultra Lyme-L4


Elanco Animal Health Transcript: AGM 2026

May 21, 2026, 8:00 AM EDT - 3 months ago

Elanco Animal Health Transcript: AGM 2026


Elanco launches Befrena for canine allergic itch

2026-05-18T11:45:28.000Z - 3 months ago

Elanco launches Befrena for canine allergic itch


Elanco price target lowered to $23 from $24 at Morgan Stanley

2026-05-15T15:52:34.000Z - 3 months ago

Elanco price target lowered to $23 from $24 at Morgan Stanley


Elanco to Participate in Upcoming Investor Conferences

May 14, 2026, 8:00 AM EDT - 3 months ago

Elanco to Participate in Upcoming Investor Conferences


Elanco price target raised to $30 from $28 at JPMorgan

2026-05-07T15:37:28.000Z - 3 months ago

Elanco price target raised to $30 from $28 at JPMorgan


Elanco price target raised to $31 from $30 at Citi

2026-05-07T11:13:56.000Z - 3 months ago

Elanco price target raised to $31 from $30 at Citi


Elanco reports Q1 adjusted EPS 40c, consensus 34c

2026-05-07T09:38:45.000Z - 3 months ago

Elanco reports Q1 adjusted EPS 40c, consensus 34c


Elanco Animal Health Earnings Call Transcript: Q1 2026

May 6, 2026, 8:00 AM EDT - 4 months ago

Elanco Animal Health Earnings Call Transcript: Q1 2026


Elanco Animal Health Earnings release: Q1 2026

May 6, 2026, 8:00 AM EDT - 4 months ago

Elanco Animal Health Earnings release: Q1 2026


Elanco Animal Health Slides: Q1 2026

May 6, 2026, 8:00 AM EDT - 4 months ago

Elanco Animal Health Slides: Q1 2026


Elanco Animal Health Quarterly report: Q1 2026

May 6, 2026, 8:00 AM EDT - 4 months ago

Elanco Animal Health Quarterly report: Q1 2026


Elanco Animal Health Reports First Quarter 2026 Results

May 6, 2026, 6:27 AM EDT - 4 months ago

Elanco Animal Health Reports First Quarter 2026 Results


Elanco Animal Health Slides: Investor presentation

May 5, 2026, 7:00 AM EDT - 4 months ago

Elanco Animal Health Slides: Investor presentation


Elanco initiated with a Buy at Citi

2026-04-15T10:20:16.000Z - 4 months ago

Elanco initiated with a Buy at Citi


Elanco Animal Health Proxy statement: Proxy filing

Apr 8, 2026, 8:00 AM EDT - 5 months ago

Elanco Animal Health Proxy statement: Proxy filing


Elanco Animal Health Proxy statement: Proxy filing

Apr 8, 2026, 8:00 AM EDT - 5 months ago

Elanco Animal Health Proxy statement: Proxy filing


Elanco Animal Health Slides: Investor presentation

Mar 2, 2026, 6:00 AM EST - 6 months ago

Elanco Animal Health Slides: Investor presentation


Elanco price target raised to $32 from $30 at Stifel

2026-02-27T13:04:51.000Z - 6 months ago

Elanco price target raised to $32 from $30 at Stifel


Elanco Animal Health Earnings Call Transcript: Q4 2025

Feb 24, 2026, 8:00 AM EST - 6 months ago

Elanco Animal Health Earnings Call Transcript: Q4 2025


Elanco Animal Health Annual report: Q4 2025

Feb 24, 2026, 8:00 AM EST - 6 months ago

Elanco Animal Health Annual report: Q4 2025


Elanco Animal Health Earnings release: Q4 2025

Feb 24, 2026, 8:00 AM EST - 6 months ago

Elanco Animal Health Earnings release: Q4 2025


Elanco Animal Health Slides: Q4 2025

Feb 24, 2026, 8:00 AM EST - 6 months ago

Elanco Animal Health Slides: Q4 2025


Elanco Animal Health Slides: Investor presentation

Feb 24, 2026, 6:30 AM EST - 6 months ago

Elanco Animal Health Slides: Investor presentation


Elanco Announces Updates to Board of Directors

Feb 13, 2026, 9:24 AM EST - 6 months ago

Elanco Announces Updates to Board of Directors


Elanco Animal Health Transcript: Investor Day 2025

Dec 9, 2025, 9:00 AM EST - 9 months ago

Elanco Animal Health Transcript: Investor Day 2025


Elanco Animal Health Slides: FY 2025

Dec 9, 2025, 9:00 AM EST - 9 months ago

Elanco Animal Health Slides: FY 2025


Elanco executive appointed as Neurizon's Board Observer

Nov 26, 2025, 6:15 PM EST - 9 months ago

Elanco executive appointed as Neurizon's Board Observer


Elanco to Participate in the Upcoming Investor Conferences

Nov 20, 2025, 8:00 AM EST - 9 months ago

Elanco to Participate in the Upcoming Investor Conferences


Elanco Animal Health Earnings Call Transcript: Q3 2025

Nov 5, 2025, 8:00 AM EST - 10 months ago

Elanco Animal Health Earnings Call Transcript: Q3 2025


Elanco Animal Health Quarterly report: Q3 2025

Nov 5, 2025, 8:00 AM EST - 10 months ago

Elanco Animal Health Quarterly report: Q3 2025


Elanco Animal Health Earnings release: Q3 2025

Nov 5, 2025, 8:00 AM EST - 10 months ago

Elanco Animal Health Earnings release: Q3 2025


Elanco Animal Health Slides: Q3 2025

Nov 5, 2025, 8:00 AM EST - 10 months ago

Elanco Animal Health Slides: Q3 2025


Elanco Animal Health Reports Third Quarter 2025 Results

Nov 5, 2025, 6:27 AM EST - 10 months ago

Elanco Animal Health Reports Third Quarter 2025 Results


Elanco to Host Investor Day on December 9

Oct 16, 2025, 4:32 PM EDT - 11 months ago

Elanco to Host Investor Day on December 9


Elanco Animal Health Earnings Call Transcript: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 1 year ago

Elanco Animal Health Earnings Call Transcript: Q2 2025


Elanco Animal Health Quarterly report: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 1 year ago

Elanco Animal Health Quarterly report: Q2 2025


Elanco Animal Health Earnings release: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 1 year ago

Elanco Animal Health Earnings release: Q2 2025


Elanco Animal Health Slides: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 1 year ago

Elanco Animal Health Slides: Q2 2025


Elanco Animal Health Reports Second Quarter 2025 Results

Aug 7, 2025, 6:27 AM EDT - 1 year ago

Elanco Animal Health Reports Second Quarter 2025 Results


Elanco's dog flu vaccine gets USDA nod

Jul 9, 2025, 10:01 AM EDT - 1 year ago

Elanco's dog flu vaccine gets USDA nod


prismmarketview
prismmarketview Aug. 26 at 5:34 PM
Happy National Dog Day from PRISM MarketView! Somewhere along the way, dogs went from pets to family, and we spend on them like it. That devotion is one of the market's most durable themes, and you can trace it right across PRISM's Pet Care index: At the vet: Elanco's $ELAN once-daily itch pill for dogs, Zenrelia, just crossed blockbuster status and now reaches ~18,000 U.S. clinics, going head-to-head with Zoetis's Apoquel in a ~$1.7B canine dermatology market. It helped lift Elanco's full-year outlook this month. At the bowl: fresh and premium food ( $FRPT ) keeps turning "dog food" into a category we obsess over. At the checkout: $CHWY and $WOOF (Petco) handle the food, toys, and grooming runs; Petco reports earnings this Thursday. At the safety net: pet insurance ( $TRUP ) is now a real household line item, because we cover them like our own. From the exam room to the food bowl, caring for our dogs is a resilient (and growing) market.
0 · Reply
Jblack500
Jblack500 Aug. 25 at 7:20 PM
$VRTX $MRK $ELAN $HALO forgot to mention HALO new ath as well. Phenomenal earnings recently
0 · Reply
Jblack500
Jblack500 Aug. 25 at 7:19 PM
$VRTX $MRK $ELAN a few new ath's in some of my bios in vrtx mrk...elan reclaimed 50 day ma today. Quite a bit of insider buying in ELAN after earnings
0 · Reply
TaoistTrader
TaoistTrader Aug. 25 at 10:29 AM
0 · Reply
Form4Alerts
Form4Alerts Aug. 21 at 9:08 PM
$ELAN — Director Lawrence Erik Kurzius bought $936K · This increased their stake by 27%. · Largest purchase they've ever made in it. Not investment advice.
0 · Reply
Jblack500
Jblack500 Aug. 20 at 12:05 AM
$MRK $VRTX $GILD $HALO $ELAN ARWR BMY ANIP (May be looking at adding REGN with this breakout) https://www.fool.com/coverage/filings/2026/08/19/director-s-confidence-visible-as-elanco-leader-buys-10-000-shares/
0 · Reply
Jblack500
Jblack500 Aug. 18 at 5:15 PM
$VRTX $ELAN $MRK $GILD $HALO ARWR BMY current basket...vrtx recent new position...added to ELAN today. Sell-off after er created opportunity. Multiple insiders made open market buys on 8/7 near this level.
0 · Reply
STACKD0E
STACKD0E Aug. 17 at 5:57 PM
0 · Reply
MisterBizness
MisterBizness Aug. 13 at 10:38 PM
$ELAN nice s
0 · Reply
topstockalerts
topstockalerts Aug. 13 at 8:09 PM
Fitch Ratings upgraded Elanco Animal Health’s Long-Term Issuer Default Rating to ‘BB+’ from ‘BB’, while raising its senior secured debt rating to ‘BBB-’ from ‘BB+’ and senior unsecured debt to ‘BB+’ from ‘BB’. The outlook remains stable. The upgrade reflects Elanco’s improved competitive position, market-share gains in pet health, broad product portfolio, consistent cash generation and conservative financial policy. Since 2024, the company has reduced debt by approximately $650M through June 30, 2026, while EBITDA has increased more than 10%. Fitch expects leverage to remain below 3.5x and decline toward 3.0x by the end of 2027. Fitch forecasts free cash flow to improve from $345M in 2026 to about $575M in 2028, driven by innovation-led margin expansion, cost savings, productivity gains and working-capital management. EBITDA margins are expected to reach 21% in 2026 and remain around 21%-22% thereafter. $ELAN
0 · Reply
TaoistTrader
TaoistTrader Aug. 12 at 10:01 PM
$ELAN might be time to add some more
0 · Reply
Estimize
Estimize Aug. 12 at 10:01 AM
Wall St is expecting 0.20 EPS for $ELAN Q3 [Reporting 11/10 BMO] http://www.estimize.com/intro/elan?chart=historical&metric_name=eps&utm_co
0 · Reply
Jblack500
Jblack500 Aug. 11 at 5:41 PM
$HALO $ELAN $ARWR $VRTX $GILD MRK BMY ANIP... Current basket...started position in VRTX, heading to 600 and will add more on dips. Reduced BMY
1 · Reply
FilingTracker
FilingTracker Aug. 10 at 8:14 PM
$ELAN Insider purchase: https://filingtracker.ai/sec-filing/elan/form-4/2026-08-10/1739104/0001374175-26-000005
0 · Reply
garygb
garygb Aug. 8 at 1:51 PM
$ELAN Saturdays are my day to examine my losing holdings. Elanco has shown no elan. (French pun lol). Doubling down.
0 · Reply
STACKD0E
STACKD0E Aug. 7 at 8:05 PM
0 · Reply
RMAW
RMAW Aug. 7 at 7:46 PM
$ELAN WHAT IN THE ACTUAL FUCK!!!!
0 · Reply
Bogeymakr
Bogeymakr Aug. 7 at 7:18 PM
$ELAN Wonder which criminal hedgies shorting this down today... down more than $ZTS which was downgraded.
0 · Reply
Bogeymakr
Bogeymakr Aug. 7 at 5:16 PM
$ELAN Very good earnings ... scratching my head on this one. nibbled.
0 · Reply
prismmarketview
prismmarketview Aug. 7 at 2:35 PM
The FDA just granted $ELAN an Emergency Use Authorization for CLiK Extra, a wound spray that prevents New World screwworm in livestock and wildlife — from cattle and sheep to bison and Sonoran pronghorn. Yet shares slipped ~2% on the news. Here's why 👇 https://prismmarketview.com/elanco-wins-fda-emergency-authorization-for-new-world-screwworm-drug/
0 · Reply
TaoistTrader
TaoistTrader Aug. 7 at 1:34 PM
$ELAN added
0 · Reply
WAJeff
WAJeff Aug. 7 at 3:04 AM
$ELAN Last of this was sold at 27.25 on 8/5
1 · Reply